Some neuro risks start quietly in your genes. We identify them early
Genes like APOE, LRRK2 and MAPT can silently increase your risk for Alzheimer’s or Parkinson’s. CENT AI’s NeuroSense analysis detects these early, so you can protect cognition and longevity while your brain is still healthy.
Why It’s Important?
The Stats You Can’t Ignore
CENT AI is built on clinical evidence and not assumptions. These genetic facts explain why early, accurate DNA analysis truly matters.
Late-onset Alzheimer’s disease has heritability estimates around 70–80%, indicating a strong genetic component alongside environment and lifestyle
Source: PMC
What all gets covered?
Comprehensive Genetic Screening for Neuro Risk
We includes hereditary gene analysis for neurodegenerative pathways and vascular brain risks, combined with PRS to quantify polygenic contributions to long-term neurological health.
Alzheimer’s Disease
Long-term risk of memory decline
PRS
What We Test For
PRS estimates your overall genetic susceptibility to late-onset Alzheimer’s by analysing genome-wide markers (including APOE-related signal).
Key Genes Analyzed
PRS: genome-wide SNP markers for Alzheimer’s risk
Parkinson’s Disease
Genetic risk for movement disorder causing tremors, slowness, and stiffness.
PRS
What We Test For
PRS measures your broader genome-wide tendency to develop Parkinson’s later in life. NGS checks for rare inherited mutations that cause familial or early-onset Parkinson’s.
Key Genes Analyzed
PRS:genome-wide SNP markers associated with Parkinson’s disease.
FAQ
Frequently Asked Questions
This screening analyses your DNA across all four major disease systems—Heart, Cancer, Neuro, and Metabolic—using both Next-Generation Sequencing (NGS) for high-impact genes and Polygenic Risk Scoring (PRS) for common, multi-gene risks.
Since your DNA doesn’t change, genetics is typically a once-in-a-lifetime test.
But your personalised screening plan is updated as medical science evolves.
Yes. Genetics allows you to:
Detect risks decades before symptoms
Personalise screening (MRI frequency, calcium score, cancer surveillance, etc.)
Modify lifestyle based on your actual biology
Take early actions that can reduce risk by 30–70%, depending on the condition
Most consumer DNA tests only analyse a few markers or ancestry data.
CENT AI performs clinical-grade sequencing + PRS across thousands of markers and medically important genes—validated for preventive healthcare, not recreation.
